GlucoTrack, Inc. (GCTK) — Stock Valuation & Research

GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.

GCTK key statistics

Price$0.41
Market cap$163,620
SectorHealthcare
IndustryMedical - Devices
ExchangeNASDAQ
52-week range0.37-207
Beta0.72

Explore GCTK's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.